Inventiva (IVA) Receivables (2018 - 2025)
Inventiva's (IVA) quarterly Receivables came in at $2.5 million in Q4 2025, up 292.86% year-on-year from $627265.5 in Q4 2024, and down 99.98% quarter-over-quarter from $12.2 billion in Q2 2025.
Inventiva (IVA) Receivables (2018 - 2025) Analysis & Trends
Inventiva's Receivables history runs 8 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- On a quarterly basis, Receivables rose 292.86% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 292.86% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 292.86% from the prior year.
- Receivables retreated to $2.5 million in Q4 2025 per IVA's latest filing, from $12.2 billion in the prior quarter.
- Across five years, Receivables topped out at $12.2 billion in Q2 2025 and bottomed at $165280.1 in Q4 2022.
- The 5-year median for Receivables is $4.9 million (2022), against an average of $1.1 billion.
- Across the five-year window, Receivables tumbled 96.64% in 2022 and surged 123747.24% in 2025, its largest moves.
- Year by year, Receivables stood at $4.9 million in 2021, then sank by 96.64% to $165280.1 in 2022, then soared by 2661.46% to $4.6 million in 2023, then sank by 86.26% to $627265.5 in 2024, then surged by 292.86% to $2.5 million in 2025.
- Per Business Quant, the three latest IVA Receivables figures stand at $2.5 million (Q4 2025), $12.2 billion (Q2 2025), and $627265.5 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.46 Mn |
| Jun 30, 2025 | 12.19 Bn |
| Dec 31, 2024 | 627,265.50 |
| Jun 30, 2024 | 9.84 Mn |
| Dec 31, 2023 | 4.56 Mn |
| Jun 30, 2023 | 8.11 Mn |
| Dec 31, 2022 | 165,280.07 |
| Jun 30, 2022 | 4.86 Mn |
| Dec 31, 2021 | 4.91 Mn |
| Jun 30, 2021 | 9.59 Mn |
| Mar 31, 2021 | 1.55 Mn |
| Dec 31, 2020 | 1.04 Mn |
| Jun 30, 2020 | 9.28 Mn |
| Dec 31, 2019 | 711,728.77 |
| Dec 31, 2018 | 969,045.57 |